[90% of maximum predicted during the last minutes of the test. 4 Although data are available Background -The repeatability of the response to standardised treadmill exercise on the reproducibility of the response to standardised exercise testing, 4-7 data for dry air extesting using dry air and monitoring of heart rate in asthmatic children suffering ercise testing in children are lacking. We have therefore investigated the repeatability of EIB from exercise-induced bronchoconstriction (EIB) has not been well established.
used, and if the duration of the two tests did tion (EIB) is regarded as an expression of P J Sterk not differ by more than 30 seconds. airway hyperresponsiveness to non-sensitising bronchoconstrictor stimuli, which is a common characteristic of current symptomatic asthma. 
Rotterdam, The
One of the goals of asthma treatment is to   Netherlands enable the patients to participate in activities Before exercise the baseline FEV 1 was meas- untary ventilation 3 or, alternatively, a heart rate was monitored by a radiographic device (Polar Sport Tester). The incline of the treadmill was set at 5-10%, depending on the physical condition of the child. During the first minute of the test the children walked at a slow speed to familiarise themselves again with the procedure. Subsequently, the speed of the treadmill was increased during the first three minutes of the test to induce a heart rate of [90% of the predicted maximum (approximately 210 -age) 4 by the third minute of the test. Thereafter, the children ran for another three minutes unless dyspnoea made further running impossible. FEV 1 was measured in duplicate at 1, 3, 5, 7.5, 10, 15, 20 and 30 minutes after running, with the highest FEV 1 at each time point being retained for analysis.
  
The severity of EIB was expressed as the maximal percentage decrease in FEV 1 after exercise compared with the baseline FEV 1 (% fall) and as the area under the time-response curve (AUC) between 0 and 30 minutes after exercise. The values on the test days of heart rate nificant. Analysis of repeatability was performed by calculating the intra-class correlation coefficient (between subject variance/within+ values for the same and , but based on n -1 between subject variance) according to pubdegrees of freedom (with n=estimated sample lished guidelines. 8 size).) Curves for estimation of sample size were constructed using within subject variability measurements and published power functions Results (one sided) for predicting sample size.
9 For All children completed the study according to comparison of active versus placebo treatment the protocol. Between children, the duration of the change over time in the outcome variable the exercise tests varied from 3.5 to 6 minutes. was chosen as the main efficacy parameter, the Mean (SD) heart rate during the last minute treatment induced change over time being a of the test did not differ significantly between more sensitive indicator of drug effect than the the test days (188 (9)/min and 189 (8)/min, absolute values of the outcome variable at each respectively, p=0.44). The mean (SD) % fall time point of measurement. Assuming absence for the first test was 32.1 (10.5)%, and for the of period or carryover effects, the approximate repeat test 31.7 (10.3)%. Mean AUC was 582 number of subjects required in a crossover (307)%min for test 1, and 596 (297)%min for design study was subsequently calculated using test 2. Severity of EIB did not differ significantly the formula: between the two tests (% fall, p=0.87; AUC: N (number of subjects)= p=0.80). Because the differences in % fall and AUC between the two tests were proportional
to their mean, both parameters were log-transwhere Sdd is the standard deviation of the formed, thereby achieving normality of the change in outcome variable, Z is the standard differences (fig 1) . The intra-class correlation normal deviate corresponding to a right-hand coefficients (based on these log-transformed tail area of , Z is the standard normal deviate data) were 0.57 for % fall and 0.67 for AUC. corresponding to a left-hand tail area of , Curves for estimation of sample sizes at given and D is the expected mean change in EIB power levels were constructed for parallel group produced by treatment -that is, 40%, 50%, studies (fig 2) and for crossover studies (not etc.
shown). The standard deviation of difference For a parallel group design study, comparing (Sdd) in EIB for the two tests used in the the change over time of the outcome variable formulae to calculate sample size was 0.296 for for the two groups, the number of subjects was the log e -transformed data of % fall, and 0.416 calculated according to the formula:
for the log e -transformed data of AUC. The estimated sample sizes needed at different N (number of subjects)= power levels to discriminate statistically sig-
2 in each group. nificant reductions in EIB of 40% and 50%, respectively, are presented in table 1, the re-(Caveat: With estimated sample sizes of Ζ30, Z values should be replaced by Student's t quired number of subjects being dependent on that study, a 95% range of ±12% was calculated, meaning that there is a 95% chance of the true value for a subject to be found within the range of 12% fall in FEV 1 around the single measurement value. However, when re-analysing the published data in children with at least 20% fall in FEV 1 post-exercise (comparable to our study population), we have estimated the single determination 95% range to be ±18.5%.
7 Secondly, in the studies published different indices of repeatability are used such as coefficient of variation (CV=standard deviation divided by mean), 4 5 intra-class correlation coefficient, 6 or 95% CI of a single measurement. 7 The CV is only to be used when the standard deviation is proportional to the mean, 10 otherwise the CV will vary with the mean value of EIB, as was elegantly shown for has recently been advised because, in all circumstances, the intra-class correlation co- standardised dry air exercise testing is adequate enough to allow drug evaluation for EIB in
